Last 802.60 INR
Change Today -0.80 / -0.10%
Volume 5.5K
ASTR On Other Exchanges
Symbol
Exchange
Natl India
As of 6:05 AM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

astrazeneca pharma india ltd (ASTR) Snapshot

Open
804.10
Previous Close
803.40
Day High
808.00
Day Low
796.95
52 Week High
03/4/14 - 1,286
52 Week Low
01/30/14 - 725.20
Market Cap
20.1B
Average Volume 10 Days
7.5K
EPS TTM
-0.20
Shares Outstanding
25.0M
EX-Date
07/9/12
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ASTRAZENECA PHARMA INDIA LTD (ASTR)

Related News

No related news articles were found.

astrazeneca pharma india ltd (ASTR) Related Businessweek News

No Related Businessweek News Found

astrazeneca pharma india ltd (ASTR) Details

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. The company primarily offers products in the areas of cardiovascular and metabolic diseases; oncology; respiratory, inflammation, and autoimmunity; and infection, neuroscience, and gastrointestinal diseases. It also provides clinical trial services on pharmaceutical products. The company was founded in 1979 and is headquartered in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

1,559 Employees
Last Reported Date: 09/11/14
Founded in 1979

astrazeneca pharma india ltd (ASTR) Top Compensated Officers

Managing Director, Director, Member of Share ...
Total Annual Compensation: 12.3M
Compensation as of Fiscal Year 2014.

astrazeneca pharma india ltd (ASTR) Key Developments

AstraZeneca Pharma India Limited Resignation of Robert Haxton as Wholetime Director

AstraZeneca Pharma India Ltd. announced that Mr. Robert Haxton has resigned as the Wholetime Director of the company. The Board has accepted the resignation of Mr. Haxton and that he would be relieved from the said position, effective December 14, 2014.

AstraZeneca Pharma India Announces Resignation of Robert Haxton as Wholetime Director, Effective from December 14, 2014

AstraZeneca Pharma India informed that Robert Haxton has resigned as the Wholetime Director of the company. The board has accepted the resignation of Haxton and that he would be relieved from the said position, effective December 14, 2014.

AstraZeneca Pharma India Ltd Appoints Rebekah Martin as an Additional Director

AstraZeneca Pharma India Ltd. announced that the board of directors of the company at its meeting held on November 03, 2014, has appointed Ms. Rebekah Martin as an Additional Director of the company, effective November 03, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ASTR:IN 802.60 INR 0.00

ASTR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ASTR.
View Industry Companies
 

Industry Analysis

ASTR

Industry Average

Valuation ASTR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.0x
Price/Book 11.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTRAZENECA PHARMA INDIA LTD, please visit www.astrazenecaindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.